SCHEMBL27645178

SCHEMBL27645178

c1ccc(CCCC2CCN(c3ccnc4ccccc34)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.51
NCF1 P14598 1/20 0.51
KCNH2 Q12809 2/20 0.51
ACHE P22303 5/20 0.49
SLC18A3 Q16572 1/20 0.45
NMT1 P30419 1/20 0.44
F10 P00742 2/20 0.43
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
CYP2C9 P11712 1/20 0.42
DRD4 P21917 1/20 0.41
PDE10A Q9Y233 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28761502 0.95 KCNH2 (0.52) ADRB2NCF1KCNH2ACHESLC18A3
SCHEMBL27645112 0.84 NMT1 (0.43) ADRB2NCF1KCNH2ACHESLC18A3
SCHEMBL2089595 0.83 NMT1 (0.46) ADRB2NCF1KCNH2ACHESLC18A3
SCHEMBL2096547 0.83 SLC18A3 (0.41) ACHESLC18A3NMT1PDE10A
SCHEMBL2093497 0.82 NMT1 (0.42) KCNH2ACHESLC18A3NMT1DRD2
SCHEMBL27645182 0.82 NMT1 (0.44) ADRB2NCF1KCNH2ACHENMT1
SCHEMBL27666211 0.82 NMT1 (0.44) ADRB2NCF1KCNH2ACHENMT1
SCHEMBL27666325 0.80 KCNH2 (0.73) ADRB2NCF1KCNH2DRD2DRD3
SCHEMBL29722401 0.79 ADRB2 (0.58) ADRB2NCF1KCNH2F10DRD2
SCHEMBL18980471 0.79 ADRB2 (0.58) ADRB2NCF1KCNH2F10DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed